前蛋白转化酶枯草溶菌素9(PCSK9)单克隆抗体
Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
FH3; HCHOLA3; NARC1; Hypercholesterolemia,Autosomal Dominant 3; Neural apoptosis-regulated convertase 1; Proprotein convertase 9; Subtilisin/kexin-like protease PC9
- 编号MAE189Ra23
- 物种Rattus norvegicus (Rat,大鼠) 相同的名称,不同的物种。
- 来源单抗制备
- 宿主小鼠
- 效价(克隆号)C1
- Ig亚型 IgG1 Kappa
- 纯化方式蛋白A + 蛋白G亲和纯化
- 标记物无标记物
- 免疫原 RPE189Ra01-前蛋白转化酶枯草溶菌素9(PCSK9)重组蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性状液体
- 浓度1mg/mL
- 且适物种-
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术,请参见流式抗体。 - 下载 英文说明书 中文说明书
- 规格 20µl100µl 200µl 1ml 10ml
- 价格 ¥ 745 ¥ 1739 ¥ 2484 ¥ 6210 ¥ 24840
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
该抗体是针对PCSK9的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别PCSK9。
用法
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
赠品
增值服务
相关产品
编号 | 适用物种:Rattus norvegicus (Rat,大鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPE189Ra01 | 前蛋白转化酶枯草溶菌素9(PCSK9)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAE189Ra01 | 前蛋白转化酶枯草溶菌素9(PCSK9)多克隆抗体 | WB; IHC; ICC; IP. |
MAE189Ra23 | 前蛋白转化酶枯草溶菌素9(PCSK9)单克隆抗体 | WB; IHC; ICC; IP. |
MAE189Ra22 | 前蛋白转化酶枯草溶菌素9(PCSK9)单克隆抗体 | WB; IHC; ICC; IP. |
MAE189Ra21 | 前蛋白转化酶枯草溶菌素9(PCSK9)单克隆抗体 | WB; IHC |
SEE189Ra | 前蛋白转化酶枯草溶菌素9(PCSK9)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LME189Ra | 前蛋白转化酶枯草溶菌素9(PCSK9)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Biological Trace Element Research | Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers [pubmed:28409410] |
BASIC RESEARCH IN CARDIOLOGY | Autocrine effects of PCSK9 on cardiomyocytes [Pubmed: 33169229] |
J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans [33407555] |
Metabolism | MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice [33775647] |
Eur Rev Med Pharmacol Sci | Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders [34533801] |
Clin Exp Hypertens | Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease [Pubmed:35502687] |
留言咨询